3D Cellular Competitors

CELLINK is proud to be part of BICO. BICO is a lab automation partner and provider of selected workflows to pharma and biotech. With 48,000+ instruments installed in over 65 countries, BICO products, software, and solutions are found in more than 3,500 laboratories, including the world’s top 20 pharmaceutical companies, and have been cited in over 11,900 publications. Operating through three business areas – Lab Automation, Life Science Solutions, and Bioprinting – BICO strives towards the vision to enable and automate the life science lab of the future. BICO is listed on Mid-Cap, Nasdaq Stockholm under BICO.

Geltor is the biodesign company that audaciously imagines and deeply explores all the possibilities that the tree of life has to offer. With customer benefit at the fore of each step of the creative process, Geltor has created the largest selection of designer proteins that are crafted with unparalleled biocompatibility and functionality. These proteins are 100% animal- and GMO-free, globally scalable, and sustainably cultivated. Geltor’s products are the result of endless curiosity and ceaseless optimization, clinically demonstrated for high performance.

Aspect Biosystems is a biotechnology company pioneering the development of a novel category of cellular medicines designed to replace or restore biological function and deliver curative therapies for some of the most elusive diseases. Aspect is developing these bioengineered cellular medicines by applying its full-stack tissue therapeutic platform, which integrates proprietary AI-powered bioprinting technology, therapeutic cells, hypoimmune cell engineering, and advanced biomaterials. Aspect is advancing its therapeutic pipeline across multiple endocrine and metabolic diseases, including diabetes and rare endocrine disorders.